EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients

Hadiza Rabe Musa, Amina Rabe Musa, Yahuza Gimba Muhammed, Usman Salisu Batagarawa, Aminu Ibrahim

BioMed Target Journal · 2024

DOI: 10.59786/bmtj.223 ↗
AbstractBibliografische Angaben

Abstract

Diabetic retinopathy, a serious complication of diabetes, may be influenced by genetic factors, including the Aldose Reductase (ALR2) gene polymorphism. There is a crucial need to understand how the polymorphism in the ALR2 gene contributes to diabetic retinopathy. This study aimed to explore and evaluate the impact of ALR2 gene polymorphism on diabetic retinopathy, alongside assessing inflammatory markers and antioxidant status among diabetic patients residing in Kano State, Nigeria. In this study, 40 participants were enrolled; the participants were divided into 4 groups, with three test groups (diabetes mellitus, cataract, and diabetic retinopathy groups) and the control group. The investigation encompassed and incorporated the prevalence of the SNP C(-106)T polymorphism within the ALR2 promoter region, in combination with the assessment of inflammatory markers (C-reactive protein [CRP] and high-sensitivity C-reactive protein [hsCRP]), malondialdehyde (MDA) levels, vitamin A and aldose reductase concentrations. The findings revealed a 6.7% prevalence of the SNP C(-106)T polymorphism. Fasting blood glucose and HbA1c levels were significantly (p 0.05) observed correlation between ALR2 and MDA (r= 0.026) or CRP (r= -0.077). The study identified a 6.7% prevalence of ALR2 gene polymorphism in diabetic retinopathy patients, alongside elevated inflammatory markers and MDA levels. Moreover, in the present finding, all control group had the C (CC genotype) allele, while the study group had 90% C allele and 10% T allele. The T allele showed no significant association with DR 1.00 (OR 95% CI: 0.127-7.893; p:1.00). However, Additional research with larger sample sizes is warranted to comprehensively investigate the implications of the SNP C(-106)T polymorphism at the ALR2 promoter region.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →